OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammatory Chemokines in Atherosclerosis
Selin Gencer, Bryce Evans, Emiel P. C. van der Vorst, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 226-226
Open Access | Times Cited: 134

Showing 26-50 of 134 citing articles:

Immunity in Atherosclerosis: Focusing on T and B Cells
Anastasia V. Poznyak, Evgeny E. Bezsonov, Т. В. Попкова, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8379-8379
Open Access | Times Cited: 31

miR‐195‐3p alleviates homocysteine‐mediated atherosclerosis by targeting IL‐31 through its epigenetics modifications
Jiantuan Xiong, Fang Ma, Ning Ding, et al.
Aging Cell (2021) Vol. 20, Iss. 10
Open Access | Times Cited: 30

Key Chemokine Pathways in Atherosclerosis and Their Therapeutic Potential
Andrea Bonnin Márquez, Emiel P. C. van der Vorst, Sanne L. Maas
Journal of Clinical Medicine (2021) Vol. 10, Iss. 17, pp. 3825-3825
Open Access | Times Cited: 27

Endothelial ACKR3 drives atherosclerosis by promoting immune cell adhesion to vascular endothelium
Selin Gencer, Yvonne Döring, Yvonne Jansen, et al.
Basic Research in Cardiology (2022) Vol. 117, Iss. 1
Open Access | Times Cited: 21

Novel Anti-Inflammatory Therapies in Coronary Artery Disease and Acute Coronary Syndromes
Yannis Dimitroglou, Constantina Aggeli, Panagiotis Theofilis, et al.
Life (2023) Vol. 13, Iss. 8, pp. 1669-1669
Open Access | Times Cited: 12

Endothelial Dysfunction as a Key Link between Cardiovascular Disease and Frailty: A Systematic Review
Hakan Calila, Elena Bălăşescu, Roxana Nedelcu, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 9, pp. 2686-2686
Open Access | Times Cited: 4

Annexin A8 deficiency delays atherosclerosis progression
Carmen Gutiérrez‐Muñoz, Rafael Blázquez‐Serra, Irene San Sebastián-Jaraba, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access

Lysosome Functions in Atherosclerosis: A Potential Therapeutic Target
Zhengchao Wang, Xiang Li, Alexandra K. Moura, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 183-183
Open Access

The Role of Neutrophil Extracellular Traps in Atherosclerosis: From the Molecular to the Clinical Level
Yongfang Yuan, Changxin Sun, Xinyi Liu, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 4421-4433
Open Access

Associations and mediators between vitiligo and cardiovascular diseases: a Mendelian randomization study
Xiaoyan Zhang, Lei Pu, Pu Cheng, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Age, inflammation, alkaline phosphatase, and coronary artery calcification in firefighters
Mingyue Li, Jiali Han, Carolyn M. Muegge, et al.
BMC Cardiovascular Disorders (2025) Vol. 25, Iss. 1
Open Access

Isoechinulin-Type Diketopiperazines with Anti-monocyte Adhesion Activities from a Sponge-Associated Aspergillus sp
Weihao Chen, Jixiang Ma, Mengjing Cong, et al.
Journal of Natural Products (2025)
Closed Access

Characteristics of the gut microbiota of patients with symptomatic carotid atherosclerotic plaques positive for bacterial genetic material
Hang Lv, Zhiyuan Zhang, Bo Fu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 13
Open Access | Times Cited: 3

Current targeting strategies and advanced nanoplatforms for atherosclerosis therapy
Yingchao Li, Qixiang Feng, Luyue Wang, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 2, pp. 128-147
Closed Access | Times Cited: 3

Role of Helicobacter pylori Infection in Pathogenesis, Evolution, and Complication of Atherosclerotic Plaque
Tiziana Ciarambino, Pietro Crispino, Giovanni Minervini, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 400-400
Open Access | Times Cited: 3

Investigating the therapeutic effects and mechanisms of Carthamus tinctorius L.-derived nanovesicles in atherosclerosis treatment
Rongfeng Yang, Fengxia Lin, Wenlin Wang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3

Transcriptomic analysis reveals the critical role of chemokine signaling in the anti-atherosclerosis effect of Xuefu Zhuyu decoction
Dongdong Jia, Mengzhu Zhao, Xinyue Zhang, et al.
Journal of Ethnopharmacology (2024) Vol. 332, pp. 118245-118245
Closed Access | Times Cited: 3

Immunological perspectives on atherosclerotic plaque formation and progression
Hui Pi, Guangliang Wang, Yu Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3

Transcytosable and Ultrasound‐Activated Liposome Enables Deep Penetration of Biofilm for Surgical Site Infection Management
Guowei Wang, Chengyue Zhang, Zixuan Huang, et al.
Advanced Materials (2024)
Closed Access | Times Cited: 3

TDP43 Exacerbates Atherosclerosis Progression by Promoting Inflammation and Lipid Uptake of Macrophages
Ning Huangfu, Yong Wang, Zhenyu Xu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 23

D‐dopachrome tautomerase in cardiovascular and inflammatory diseases—A new kid on the block or just another MIF?
Chunfang Zan, Bishan Yang, Markus Brandhofer, et al.
The FASEB Journal (2022) Vol. 36, Iss. 11
Open Access | Times Cited: 15

Rosuvastatin Attenuates Progression of Atherosclerosis and Reduces Serum IL6 and CCL2 Levels in Apolipoprotein-E-deficient Mice
Diamantis I. Tsilimigras, Kalliopi Thanopoulou, Maria Salagianni, et al.
In Vivo (2023) Vol. 37, Iss. 3, pp. 994-1002
Open Access | Times Cited: 8

Inflammation and Atherosclerosis
Klaus Ley
Cells (2021) Vol. 10, Iss. 5, pp. 1197-1197
Open Access | Times Cited: 18

Scroll to top